CHIMIA (Sep 2022)

A Challenge: Controlling the Quality of Cell and Gene Therapies

Christoph Meyer,
Alexander Sandoval,
Allyson Decker,
Sophia Nguyen,
Susan Barr,
Andreas Wirth

Affiliations

Christoph Meyer: Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Alexander Sandoval: Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Allyson Decker: Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Sophia Nguyen: Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Susan Barr: Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel
Andreas Wirth: Lonza Pharma AG, Cell and Gene Therapies, Hochbergerstrasse 60A, CH-4057 Basel

DOI: https://doi.org/10.2533/chimia.2022.794
Journal volume & issue: Vol. 76, no. 9

Abstract

No abstracts available.

Published in CHIMIA

ISSN: 0009-4293 (Print); 2673-2424 (Online)
Publisher: Swiss Chemical Society
Country of publisher: Switzerland
LCC subjects: Science: Chemistry
Website: http://chimia.ch

About the journal